with no proven treatment for covid 19 and a vaccine at least 12 months away scientists and pharmaceutical companies are searching for a shorter term solution to help treat patients one promising option is the use of antibody drugs four u s biotech companies amgen genentech gilead and regeneron are working on experimental drugs cbs news spoke with regeneron president and chief scientific officerdr george yancopoulosabout the possible treatments for tuesday s cbs evening news here are our top takeaways from that interview there are natural signals in the body that drive beneficial immune and inflammatory responses dr yancopoulos told us the problem is oftentimes these immune and inflammatory responses can become excessive and they can create more damage than good and the hope is by using this antibody that specifically blocks this one inflammatory pathway it can actually benefit the inflammation that s seen in lungs that s causing people to have the difficulties breathing and eventually succumbing to this tragic disease the regeneron antibody drug kevzara is being used in a controlled study to treat critical patients across the country dr yancopoulos explained that the drug was first tried in china for treating coronavirus and they saw some success some clever scientist in china decided to try it and they reported that yes it looked like it might be benefiting the inflammation that you get in the lungs in this disease and patients might be getting better he said those studies were uncontrolled anecdotal studies and we initiated a controlled study to see whether or not this really can make a difference for patients regeneron is currently working on a cocktail treatment to help prevent the spread of covid 19 until a vaccine is created and tested when you give a vaccine you are given something that induces what is known as an immune response dr yancopoulos said unfortunately it takes time to perfect the way to get the body to do it itself luckily we and others have technologies that allow us to make these exact same antibodies outside of the body and then purify them and give them back to people and it s as if these people have been vaccinated dr yancopoulos told us that the drug cocktail which could essentially function as a pre vaccine could be available widely soon by june we could be testing it and within a month or two we might know at least for certain patients if it s safe and effective so by the end of the summer we could be treating hundreds of thousands if not millions of people he said watch cbs news anytime anywhere with the our 24 7 digital news network stream cbsn live or on demand for free on your tv computer tablet or smartphone copyright 2020 cbs interactive inc all rights reserved 